The ROS level (Fig. 3D, 6039 ± 654.4 vs. 4308 ± 394.7, P = 0.03) of CD34+ cells after coculture with AML BM EPCs was significantly higher than that of lower-risk MDS BM EPCs. The gene discussed is CD34; the disease is myelodysplastic syndrome.